C07D 501/60
With a double bond between positions 3 and 4
Official title: with a double bond between positions 3 and 4
C07D501/60 (With a double bond between positions 3 and 4) appears on 33 US grants and 30 published applications in this corpus.
Search patents in C07D- Granted patents
- 33
- Published applications
- 30
- Assignees
- 23
- Inventors
- 100
- Latest grant
- 16 Apr 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 4 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 2 |
| 2010 | 1 | 1 |
| 2011 | 0 | 1 |
| 2012 | 3 | 3 |
| 2013 | 0 | 2 |
| 2014 | 4 | 3 |
| 2015 | 0 | 3 |
| 2016 | 4 | 3 |
| 2017 | 4 | 4 |
| 2018 | 3 | 4 |
| 2019 | 1 | 0 |
| 2020 | 1 | 0 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Chromogenic beta-lactamase substrate16 Apr 2024US 11,957,690 B2Brown University
- Derivatized 3-styryl-cephalosporins8 Jun 2021US 11,028,103 B2Gladius Pharmaceuticals Corporation
- Process for preparing ceftolozane from 7-aminocephalosporanic acid (7-ACA)14 Jan 2020US 10,532,058 B2Sandoz Ltd.
- Broad spectrum beta-lactamase inhibitors26 Mar 2019US 10,239,890 B2Gladius Pharmaceuticals Corporation
- Broad spectrum beta-lactamase inhibitors19 Jun 2018US 10,000,509 B2Gladius Pharmaceuticals Corporation
- A chromogenic beta-lactamase substrate19 Aug 2021US 2021/0252010 A1Brown University
- Process for Preparing Ceftolozane from 7-Aminocephalosporanic Acid (7-ACA)29 Nov 2018US 2018/0338981 A1Sandoz Ltd.
- Derivatized 3-Styryl-Cephalosporins8 Nov 2018US 2018/0319817 A1Gladius Pharmaceuticals Corporation
- Broad Spectrum Beta-Lactamase Inhibitors27 Sep 2018US 2018/0273549 A1Gladius Pharmaceuticals Corporation
- Broad Spectrum Beta-Lactamase Inhibitors8 Mar 2018US 2018/0065989 A1Gladius Pharmaceuticals Corporation
Most cited
By later US patents
- Cephalosporin compound10US 8,809,314 B1Cubist Pharmacueticals, Inc. · 2014
- Solid forms of ceftolozane10US 8,906,898 B1Calixa Therapeutics, Inc. · 2014
- Broad spectrum beta-lactamase inhibitors9US 8,883,772 B2Sopharmia, Inc. · 2014
- Broad spectrum beta-lactamase inhibitors9US 9,453,032 B2Gladius Pharmaceuticals Corporation · 2016
- Process for the manufacture of 3-substituted thiomethyl-7-amino-2-cephem-4-carboxylic acid compound6US 4,014,874 ACiba-Geigy Corporation · 1977